Evidence map›Paper›PMID 26468280›Full record

ArticleThe Journal of biological chemistry2015

Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase (SAGA) Coactivator Complexes Enhance the Acetyltransferase Activity of GCN5.

Anne Riss, Elisabeth Scheer, Mathilde Joint, Simon Trowitzsch, Imre Berger, László Tora

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anne RissFrom the Cellular Signaling and Nuclear Dynamics Program and.
Elisabeth ScheerFrom the Cellular Signaling and Nuclear Dynamics Program and.
Mathilde JointProteomics platform, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR 7104, INSERM U964, Université de Strasbourg, BP 10142, 67404 Illkirch Cedex, CU de Strasbourg, France and.
Simon TrowitzschEMBL Grenoble Outstation, 6 rue Jules Horowitz BP 181, F-38042 Grenoble Cedex, France and The School of Biochemistry, University of Bristol, University Walk, Clifton BS8 1TD, United Kingdom.
Imre BergerEMBL Grenoble Outstation, 6 rue Jules Horowitz BP 181, F-38042 Grenoble Cedex, France and The School of Biochemistry, University of Bristol, University Walk, Clifton BS8 1TD, United Kingdom.
László ToraFrom the Cellular Signaling and Nuclear Dynamics Program and laszlo@igbmc.fr.
Institut de génétique et de biologie moléculaire et cellulaire · FREuropean Molecular Biology Laboratory · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone acetyl transferases (HATs) play a crucial role in eukaryotes by regulating chromatin architecture and locus specific transcription. GCN5 (KAT2A) is a member of the GNAT (Gcn5-related N-acetyltransferase) family of HATs. In metazoans this enzyme is found in two functionally distinct coactivator complexes, SAGA (Spt Ada Gcn5 acetyltransferase) and ATAC (Ada Two A-containing). These two multiprotein complexes comprise complex-specific and shared subunits, which are organized in functional modules. The HAT module of ATAC is composed of GCN5, ADA2a, ADA3, and SGF29, whereas in the SAGA HAT module ADA2b is present instead of ADA2a. To better understand how the activity of human (h) hGCN5 is regulated in the two related, but different, HAT complexes we carried out in vitro HAT assays. We compared the activity of hGCN5 alone with its activity when it was part of purified recombinant hATAC or hSAGA HAT modules or endogenous hATAC or hSAGA complexes using histone tail peptides and full-length histones as substrates. We demonstrated that the subunit environment of the HAT complexes into which GCN5 incorporates determines the enhancement of GCN5 activity. On histone peptides we show that all the tested GCN5-containing complexes acetylate mainly histone H3K14. Our results suggest a stronger influence of ADA2b as compared with ADA2a on the activity of GCN5. However, the lysine acetylation specificity of GCN5 on histone tails or full-length histones was not changed when incorporated in the HAT modules of ATAC or SAGA complexes. Our results thus demonstrate that the catalytic activity of GCN5 is stimulated by subunits of the ADA2a- or ADA2b-containing HAT modules and is further increased by incorporation of the distinct HAT modules in the ATAC or SAGA holo-complexes.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsDNA-Binding ProteinsHistone AcetyltransferasesHumansMultiprotein Complexesp300-CBP-Associated FactorSf9 CellsSpodopteraTranscription FactorsAdaptor Proteins, Signal TransducingDNA-Binding ProteinsHistone AcetyltransferasesKAT2A protein, humanMultiprotein Complexesp300-CBP-Associated FactorTADA2A protein, humanTADA3 protein, humanTranscription Factorschromatinchromatin modificationchromatin regulationcomplexhistonehistone acetylasehistone acetylationhumanKAT2Amass spectrometry (MS)

Identifiers

PMID26468280
PMCPMC4661412
OpenAlexW2317176158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.